|
WO2004073641A2
(en)
|
2003-02-18 |
2004-09-02 |
Kevin Slawin |
Induced activation in dendritic cells
|
|
EP1699527A1
(en)
|
2004-01-02 |
2006-09-13 |
Advanced Cardiovascular Systems, Inc. |
High-density lipoprotein coated medical devices
|
|
CA3058450A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
CA2738031C
(en)
*
|
2008-09-22 |
2022-11-29 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
US20110287038A1
(en)
*
|
2010-04-16 |
2011-11-24 |
Kevin Slawin |
Method for treating solid tumors
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
WO2012112945A1
(en)
*
|
2011-02-18 |
2012-08-23 |
The Trustees Of Columbia University In The City Of New York |
Use of matrix metalloproteinase inhibitors to treat tuberculosis
|
|
IL230564B2
(en)
|
2011-07-22 |
2023-09-01 |
Csl Ltd |
Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
|
|
MX367743B
(es)
*
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
US9220759B2
(en)
*
|
2012-02-23 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US9220584B2
(en)
|
2012-03-30 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
EA039595B1
(ru)
*
|
2012-10-05 |
2022-02-15 |
Кадмон Корпорейшн, Ллк |
Нуклеиновые кислоты, кодирующие человеческие анти-vegfr-2/kdr-антитела
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
MX387277B
(es)
|
2013-03-14 |
2025-03-12 |
Contrafect Corp |
Composiciones basadas en anticuerpos neutralizantes suministrados intranasalmente para eficacia terapéutica aumentada.
|
|
ES2791598T3
(es)
|
2013-06-05 |
2020-11-05 |
Bellicum Pharmaceuticals Inc |
Métodos para inducir apoptosis parcial utilizando polipéptidos de caspasa
|
|
ES3009756T3
(en)
|
2013-08-05 |
2025-03-31 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors, such as lung cancer including nsclc
|
|
TWI636065B
(zh)
|
2013-08-05 |
2018-09-21 |
伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
JP6712428B2
(ja)
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
EP2907512A1
(en)
|
2014-02-14 |
2015-08-19 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Inhibitors of MMP-12 as antiviral Agents
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
AU2015244025B2
(en)
|
2014-04-08 |
2019-03-21 |
Boston Pharmaceuticals Inc. |
Binding molecules specific for IL-21 and uses thereof
|
|
AU2015312117A1
(en)
|
2014-09-02 |
2017-03-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
|
|
JP6718444B2
(ja)
|
2014-11-03 |
2020-07-08 |
アカデミッシュ ザイケンホイス レイデン （エイチ．オー．ディー．エヌ． エルユーエムシー） |
Ｂｏｂ１に対して指向されるＴ細胞レセプターおよびその使用
|
|
DK3354729T5
(da)
|
2015-09-24 |
2024-09-30 |
Daiichi Sankyo Co Ltd |
Anti-garp-antistof
|
|
US11780934B2
(en)
|
2016-02-05 |
2023-10-10 |
Institut Pasteur |
Use of inhibitors of ADAM12 as adjuvants in tumor therapies
|
|
JP2018105726A
(ja)
*
|
2016-12-27 |
2018-07-05 |
株式会社国際電気通信基礎技術研究所 |
心筋梗塞、認知症、および腫瘍からなる群から選択される一種を予防、または治療するための有効成分の候補物質のスクリーニング装置、スクリーニングプログラム、およびスクリーニング方法
|
|
PE20250933A1
(es)
|
2017-03-14 |
2025-04-02 |
Five Prime Therapeutics Inc |
Anticuerpos de union a vista a ph acido
|
|
MY201312A
(en)
|
2017-06-02 |
2024-02-16 |
Pfizer |
Antibodies specific for flt3 and their uses
|
|
BR112020019083A2
(pt)
|
2018-03-21 |
2020-12-29 |
Five Prime Therapeutics, Inc. |
Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
|
|
PE20210687A1
(es)
|
2018-07-11 |
2021-04-08 |
Bristol Myers Squibb Co |
Anticuerpos de union a vista a ph acido
|
|
US11332546B2
(en)
*
|
2019-05-21 |
2022-05-17 |
The Regents Of The University Of California |
Protease inhibitory antibodies and methods of use thereof
|
|
WO2021222595A2
(en)
*
|
2020-04-30 |
2021-11-04 |
Virtuoso Binco, Inc. |
Multispecific antibodies targeting cd38 and epcam and uses thereof
|
|
WO2021229306A2
(en)
*
|
2020-05-12 |
2021-11-18 |
Virtuoso Binco,Inc. |
Multispecific antibodies targeting cd38 and bcma and uses thereof
|
|
CN116368229A
(zh)
*
|
2020-09-09 |
2023-06-30 |
信达生物制药(苏州)有限公司 |
针对冠状病毒刺突蛋白的单克隆抗体及其用途
|
|
US20240288450A1
(en)
*
|
2021-06-16 |
2024-08-29 |
Arizona Board of Regents on Behalf of the Univerity of Arizona |
Systems and methods for monitoring and treating stroke
|
|
EP4610657A1
(en)
*
|
2022-10-28 |
2025-09-03 |
Keio University |
Diagnosis of immune-mediated inflammatory diseases using mmp12 as indicator, and medicine for treating immune-mediated inflammatory diseases via mmp12 inhibition
|
|
CN118530365B
(zh)
*
|
2024-06-18 |
2025-03-11 |
辽宁得康药业集团有限公司 |
特异性检测mmp12蛋白的单克隆抗体及其应用
|